Yesterday Meatable announced the opening of a new 3300-square-metre facility at the Bio Science Park in Leiden, the Netherlands, to further scale-up its cell-based pork development.

The new pilot facility is double the size of the company’s previous space and is set to enable Meatable to increase its bioreactor capacity from 50 litres to 200 litres, with 500 litres planned later. This will ensure the company has more space to test and produce large volumes of its cell-based pork products.

The new Leiden facility has opened following Meatable’s $35 million Series B raise earlier this year – it marks an important step towards commercialising its cell-based pork products. The plant’s location in the university area of Leiden provides proximity to expert knowledge and state-of-the-art facilities. This strategic position will help Meatable expand its development capacity in preparation for its commercial launch in Singapore in 2024, aligning with its mission to enable widespread accessibility of cell-based meat.

Krijn de Nood, co-founder and CEO of Meatable, said: “It is fantastic to see how we have grown from an idea of two entrepreneurs five years ago into a mature company with a tangible product that can transform how we eat meat. In this new facility, we can further scale the company’s processes and accelerate commercial launch. This brings us one step closer to our mission to create delicious cultivated meat products without harming people, animals or the planet.”

Meatable launched in 2018 and by 2020 the company had achieved many milestones including unveiling its first cell-based pork products and achieving a “world-first” breakthrough with one of the fastest processes in the industry to make cultivated meat, taking only eight days to develop one single animal cell into pork.

#Meatable #TheNetherlands